primacor milrinone lactate injection solution
sanofi-aventis u.s. llc - milrinone lactate (unii: 9k8xr81mo8) (milrinone - unii:ju9yax04c7) - 200 ug in 1 ml
corotrope 10 mg/10 ml inf. sol. i.v. amp.
sanofi belgium sa-nv - milrinone 10 mg/10 ml - solution for infusion - 1 mg/ml - milrinone 10 mg - milrinone
primacor injection 1mg/ml solution
sanofi-synthelabo canada inc - milrinone (milrinone lactate) - solution - 1mg - milrinone (milrinone lactate) 1mg - cardiotonic agents
milhardt
propharm ltd - milrinone - solution for injection / infusion - milrinone 1 mg / 1 ml - milrinone - for the treatment of refractory heart failure immediately (up to 72 hours) following cardiac surgery. for the short term ( up to 48 hours) intravenous therapy of severe refractory congestive heart failure.in pediatric population milhardt is indicated for the short-term treatment (up to 35 hours) of severe congestive heart failure unresponsive to conventional maintenance therapy (glycosides, diuretics, vasodilators and/or angiotensin converting enzyme (ace) inhibitors), and for the short-term treatment (up to 35 hours) of pediatric patients with acute heart failure, including low output states following cardiac surgery
urizone 3 g granules
adcock ingram limited - granules - see ingredients - each sachet contains fosfomycin trometamol equivalent to 3 g fosfomycin
primacor 10mg/10ml solution for injection ampoules
sanofi - milrinone - solution for infusion - 1mg/1ml
primacor injection 1mgml
sanofi-aventis singapore pte. ltd. - milrinone lactate 1.427mg eqv milrinone 1.00mg - injection - 1mg - milrinone lactate 1.427mg eqv milrinone 1.00mg 1mg
primacor 10mg/10ml injection
sanofi-aventis australia pty ltd - milrinone, quantity: 1 mg/ml - injection, solution - excipient ingredients: glucose monohydrate; lactic acid; sodium hydroxide; water for injections - primacor injection is indicated for the short term (48 hours) intravenous therapy of severe congestive heart patients in intensive care and coronary care units not responding to other therapy (e.g. digoxin, diuretics, vasodilators, including ace inhibitors). the majority of experience with intravenous primacor has been in patients receiving digoxin and diuretics. primacor is also indicated for low output states following cardiac surgery, including weaning from cardio-pulmonary bypass pump.
primacor injection solution for injection 1mg/ml
p & d pharmaceuticals limited - milrinone - solution for injection - milrinone 1 mg/ml - cardiac therapy
primacor 1mg/ml solution for injection
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - milrinone - solution for injection - milrinone 1 mg/ml - cardiac therapy